Gut bug may hold key to inflammatory bowel disease treatment
January 20th, 2010 - 3:15 pm ICT by ANIWashington, Jan 20 (ANI): A new study has shown that bacteria that produce compounds to reduce inflammation and strengthen host defences could be used to treat inflammatory bowel disease (IBD).
According to researchers, such probiotic microbes could be the most successful treatment for IBD to date.
IBD is inflammation of the gastro-intestinal tract that causes severe watery and bloody diarrhoea and abdominal pain. The most common manifestations of IBD are Crohn’s disease and ulcerative colitis.
While the exact causes are unclear, IBD is known to be the result of an overactive immune response that is linked to an imbalance of the normal types of bacteria found in the gut.
Several recent studies have identified butyric acid as a potential therapeutic agent for IBD. Some gut bacteria produce butyric acid naturally in the intestines, but in IBD patients some of these strains are heavily depleted.
Trials in mice have shown that injecting one such strain Faecalibacterium prausnitzii into the digestive tract is effective at restoring normal levels of gut bacteria and treating the symptoms of IBD.
In addition, novel identified butyrate-producing strains, such as Butyricicoccus pullicaecorum, have been shown to exert similar effects.
Butyric acid has well-known anti-inflammatory effects and is able to strengthen intestinal wall cells - making it an ideal therapeutic agent against IBD.
In addition to butyric acid, it is hypothesized that strains such as F. prausnitzii and B.pullicaecorum secrete other anti-inflammatory compounds that may enhance the therapeutic effect.
Prof. Filip Van Immerseel, a medical microbiologist from Ghent University in Belgium said that a new treatment for IBD would be welcomed.
“Conventional drug therapy has limited effectiveness and considerable side effects. Probiotics are live bacterial supplements or food ingredients, which when taken in sufficient numbers confer health benefits to the host,” he said.
The study has been published in the February issue of the Journal of Medical Microbiology. (ANI)
- Probiotic bacteria 'could help in Crohn's disease therapy' - Apr 01, 2011
- Prebiotic helps lower colon cancer risk: study - May 04, 2012
- Healthy bacteria could prevent obesity - May 26, 2011
- New probiotic can treat irritable bowels - Feb 01, 2011
- Dietary fibre can keep diseases at bay - Oct 30, 2009
- New signaling pathway linked to inflammatory disease discovered - Dec 15, 2010
- New probiotic fights inflammatory bowel diseases - Feb 01, 2011
- Bacteria that may lead to inflammatory bowel disease identified - Sep 17, 2010
- Designer probiotics could help in the fight against obesity - Dec 23, 2010
- Friendly bugs can now be delivered safely to guts - Sep 06, 2011
- Use of local anaesthetics can benefit inflammatory bowel disease sufferers - Jul 08, 2010
- Local anaesthetics may help in treatment of inflammatory bowel disease - Jun 03, 2010
- Fibre-rich diet may help maintain healthy immune system - Oct 29, 2009
- Fermented milk has therapeutic effect on chronic gastritis - Apr 10, 2010
- Lack of gut bacteria to be blamed for Crohn''s disease - Oct 21, 2008
Tags: abdominal pain, bloody diarrhoea, butyrate, conventional drug therapy, crohn s disease, defences, digestive tract, food ingredients, gastro intestinal tract, ghent university, gut bacteria, ibd, immune response, inflammatory bowel disease, medical microbiologist, therapeutic agent, therapeutic effect, types of bacteria, ulcerative colitis, university in belgium